Botox maker Galderma sees early boost from 'Ozempic face' trend as GLP-1 use climbs, CEO says
- Posted on July 23, 2026
- By CNBC
- 0 Views
- 1 min read
In brief
Generating AI summary…
Botox maker Galderma sees early boost from 'Ozempic face' trend as GLP-1 use climbs, CEO says
The aestetics company hope increased GLP-1 use will fuel demand for treatments addressing facial volume loss, sometimes dubbed "Ozempic face."
